Cyclarity Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-11-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cyclaritytx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients
Early Phase 1
Recruiting
- Conditions
- Atherosclerotic Cardiovascular DiseaseAcute Coronary Syndromes
- Interventions
- Other: Placebo
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Cyclarity Therapeutics, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT06813339
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
News
No news found